Clinical trial
Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy…
NCT01733186 · Medipost, Inc., Industry · Completed
Key facts
| NCT number | NCT01733186 |
|---|---|
| Title | Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects |
| Official title | Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects: A Phase I/IIa Clinical Trial in Patients With Focal, Full-thickness Grade 3-4 Articular Cartilage Defects of the Knee |
| Lead sponsor | Medipost, Inc., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Degeneration Articular Cartilage Knee |
| Intervention type | Biological |
| Interventions | CARTISTEM® |
| Enrollment | 12 |
| Start date | Jan 7, 2013 |
| Primary completion | Jun 2, 2017 |
| Completion | Aug 29, 2017 |
| First posted | Nov 26, 2012 |
| Last update posted | Jan 29, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: